-
14 May 2026 16:45:32
- Source: Sharecast
LONDON STOCK EXCHANGE ANNOUNCEMENT
JPMORGAN AMERICAN INVESTMENT TRUST PLC
ANNUAL GENERAL MEETING
Legal Entity Identifier: 549300QNAI4XRPEB4G65
Information disclosed in accordance with UKLR 6.4.13
The Board is pleased to announce that all of the resolutions put to shareholders at today's Annual General Meeting were passed, including the following items of Special Business:
i) to allow the Directors of the Company to exercise all powers of the Company to allot shares in the Company up to an aggregate nominal amount of £832,042, representing approximately 10% of the Company's issued ordinary share capital (excluding shares held in Treasury) as at the date of the Annual General Meeting Notice;
ii) to allow the disapplication of pre-emption rights on the allotment of new ordinary shares up to an aggregate nominal amount of £832,042;
iii) to allow the Company to make market purchases of ordinary shares up to a maximum number which is equal to 14.99% of the Company's issued share capital as at the date of the passing of the resolution; and
iv) to allow a general meeting, other than an Annual General Meeting, to be called on not less than 14 clear days' notice.
As previously announced, Ms Nadia Manzoor retired as a Non-Executive Director of the Company following the meeting. Ms Clare Brady and Mr Kevin Troup will be appointed as Non-Executive Directors of the Company with effect from 15 May 2026.
The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, www.jpmamerican.co.uk.
A summary of proxy votes received will shortly be available on the Company's website, www.jpmamerican.co.uk.
14 May 2026
For further information, please contact:
Divya Amin
For and on behalf of
JPMorgan Funds Limited - Company Secretary
0800 20 40 20 (or +44 1268 44 44 70)
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.